FATE - Fate Therapeutics Inc. (FATE) CEO Scott Wolchko on Q1 2021 Results - Earnings Call Transcript
Fate Therapeutics, Inc. (FATE) Q1 2021 Earnings Conference Call May 5, 2021 17:00 ET Company Participants Scott Wolchko - President and Chief Executive Officer Wayne Chu - Senior Vice President, Clinical development Ed Dulac - Chief Financial Officer Bob Valamehr - Chief Research and Development Officer Conference Call Participants Robyn Karnauskas - Truist Securities Ted Tenthoff - Piper Sandler Alethia Young - Cantor Yigal Nochomovitz - Citi Michael Yee - Jefferies Peter Lawson - Barclays Tazeen Ahmad - Bank of America Kelsey Goodwin - Guggenheim Daina Graybosch - SVB Mara Goldstein - Mizuho Nick Abbott - Wells Fargo Presentation Operator Good day, ladies and gentlemen and welcome to the Fate Therapeutics First Quarter 2021 Financial Results Conference Call. This call is being webcast live on the Investors section of Fate Therapeutics website at fatetherapeutics.com. [Operator Instructions] I will now turn the call over to Scott Wolchko, President and CEO of
For further details see:
Fate Therapeutics, Inc. (FATE) CEO Scott Wolchko on Q1 2021 Results - Earnings Call Transcript